AFL official logo AFL
AFL 1-star rating from Upturn Advisory
Aflac Incorporated (AFL) company logo

Aflac Incorporated (AFL)

Aflac Incorporated (AFL) 1-star rating from Upturn Advisory
$109.9
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/26/2025: AFL (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

3 star rating from financial analysts

13 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $110.85

1 Year Target Price $110.85

Analysts Price Target For last 52 week
$110.85 Target price
52w Low $95.64
Current$109.9
52w High $115.24

Analysis of Past Performance

Type Stock
Historic Profit 0.04%
Avg. Invested days 48
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/26/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 58.78B USD
Price to earnings Ratio 14.44
1Y Target Price 110.85
Price to earnings Ratio 14.44
1Y Target Price 110.85
Volume (30-day avg) 13
Beta 0.66
52 Weeks Range 95.64 - 115.24
Updated Date 12/28/2025
52 Weeks Range 95.64 - 115.24
Updated Date 12/28/2025
Dividends yield (FY) 2.02%
Basic EPS (TTM) 7.61

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 23.55%
Operating Margin (TTM) 43.27%

Management Effectiveness

Return on Assets (TTM) 2.65%
Return on Equity (TTM) 15.58%

Valuation

Trailing PE 14.44
Forward PE 14.6
Enterprise Value 64946119478
Price to Sales(TTM) 3.32
Enterprise Value 64946119478
Price to Sales(TTM) 3.32
Enterprise Value to Revenue 3.62
Enterprise Value to EBITDA -
Shares Outstanding 524113917
Shares Floating 519936729
Shares Outstanding 524113917
Shares Floating 519936729
Percent Insiders 10.72
Percent Institutions 58.98

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Aflac Incorporated

Aflac Incorporated(AFL) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Aflac Incorporated was founded in 1955 as American Family Life Assurance Company of Columbus. It began offering cancer insurance policies in 1958. Over the decades, Aflac expanded its product offerings to include a wider range of voluntary insurance products, such as accident, hospital indemnity, and life insurance. A significant milestone was its expansion into Japan, which now represents a substantial portion of its business. Aflac is known for its distinctive advertising campaigns featuring the Aflac Duck. The company has evolved from a regional insurer to a global provider of supplemental insurance.

Company business area logo Core Business Areas

  • Aflac U.S.: This segment focuses on providing voluntary supplemental insurance products in the United States. These products are typically offered through employer payroll deductions and include policies for cancer, accident, critical illness, hospital indemnity, and short-term disability. The goal is to provide financial protection to individuals and families against unexpected medical events and income loss.
  • Aflac Japan: This segment is Aflac's largest and most significant market, offering a comprehensive suite of voluntary life and medical insurance products to individuals and small businesses in Japan. Products include cancer insurance, medical insurance, and savings-type insurance. Aflac Japan is a market leader in its segment and has a strong brand presence.

leadership logo Leadership and Structure

Aflac Incorporated is a publicly traded company with a Board of Directors overseeing its strategy and operations. Key leadership positions include the Chairman of the Board, President, and CEO. The company operates through its subsidiaries, Aflac U.S. and Aflac Japan, each with its own management team responsible for respective market operations and product development.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Cancer Insurance: Aflac's flagship product, offering financial benefits to policyholders diagnosed with cancer to help cover medical and non-medical expenses. Market share data for specific product lines is not publicly detailed in terms of percentage, but Aflac is a leading provider of supplemental cancer insurance in the U.S. Key competitors include Allstate, Prudential, and various regional insurance providers.
  • Accident Insurance: Provides lump-sum benefits or income replacement to individuals who suffer injuries from accidents. This product helps cover immediate expenses and potential lost wages. Competitors include Unum, MetLife, and other disability and accident insurers.
  • Critical Illness Insurance: Pays a lump-sum benefit upon diagnosis of a covered critical illness (e.g., heart attack, stroke, cancer). This helps with out-of-pocket medical costs and lifestyle adjustments. Competitors are similar to cancer insurance providers.
  • Hospital Indemnity Insurance: Offers daily cash benefits for hospital stays, helping to offset deductibles and co-pays. Competitors include various health insurance providers and other supplemental benefit providers.
  • Life Insurance: Aflac offers various life insurance products, including term and whole life, to provide financial security for beneficiaries. Competitors include a wide range of life insurance companies like Northwestern Mutual, MassMutual, and MetLife.

Market Dynamics

industry overview logo Industry Overview

Aflac operates in the supplemental and voluntary insurance market, which is a growing segment of the broader insurance industry. This market is driven by rising healthcare costs, employer cost-shifting for benefits, and increasing consumer awareness of financial protection needs beyond basic health insurance. The industry is characterized by a mix of large, diversified insurers and specialized niche players. Key trends include digitalization, demand for personalized products, and an aging population.

Positioning

Aflac is a recognized leader in the voluntary and supplemental insurance market, particularly in the U.S. and Japan. Its competitive advantages include a strong brand recognition (especially with the Aflac Duck), an established distribution network through employers, and a long history of product innovation in its niche. The company's focus on offering easy-to-understand, affordable policies that complement primary health insurance is a key differentiator.

Total Addressable Market (TAM)

The TAM for supplemental insurance is substantial and growing. In the U.S., employers are increasingly offering voluntary benefits, and individual demand is rising. In Japan, the market for private insurance is deeply ingrained. While precise TAM figures for Aflac's specific product categories vary, the overall market for health and financial protection products is in the hundreds of billions of dollars globally. Aflac is well-positioned to capture a significant portion of this TAM due to its established market presence and product portfolio.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition and customer loyalty, especially in Japan and with the Aflac Duck in the U.S.
  • Extensive distribution network through employers, facilitating payroll deduction sales.
  • Market leadership in key product lines like cancer insurance in the U.S. and Japan.
  • Stable financial performance and strong capitalization.
  • Diversified revenue streams from both U.S. and Japan operations.

Weaknesses

  • Reliance on employer-sponsored benefit programs, which can be cyclical.
  • Exposure to foreign exchange rate fluctuations, particularly from its Japan operations.
  • Potential for increased competition from traditional health insurers expanding into supplemental products.
  • Complexity of managing international operations and regulatory environments.

Opportunities

  • Expansion of product offerings to meet evolving consumer needs (e.g., financial wellness benefits).
  • Leveraging technology and digital platforms to enhance customer experience and streamline sales.
  • Growth in the U.S. market through increased employer adoption of voluntary benefits.
  • Potential for strategic partnerships or acquisitions to expand market reach or product capabilities.
  • Addressing the needs of the growing gig economy and independent contractor workforce.

Threats

  • Changes in healthcare policy and regulation that could impact the demand for supplemental insurance.
  • Economic downturns leading to reduced consumer spending and employer-sponsored benefit cutbacks.
  • Interest rate volatility affecting investment income.
  • Increased competition and potential price wars.
  • Cybersecurity threats and data privacy concerns.

Competitors and Market Share

Key competitor logo Key Competitors

  • Unum Group (UNM)
  • MetLife, Inc. (MET)
  • Prudential Financial, Inc. (PRU)
  • Cigna Corporation (CI)
  • American Family Insurance Group (Privately held, but a competitor in certain segments)

Competitive Landscape

Aflac's competitive advantages lie in its specialized focus on voluntary/supplemental insurance and its strong brand equity, particularly in Japan. In the U.S., its employer-based distribution is a significant strength. However, competitors like Unum, MetLife, and Prudential are also major players in the group benefits and individual insurance markets, offering a broader range of products. Cigna competes heavily in employer-sponsored health and voluntary benefits. The landscape is highly competitive, with differentiation often coming from product innovation, customer service, and distribution reach.

Growth Trajectory and Initiatives

Historical Growth: Aflac has experienced consistent historical growth, primarily driven by the expansion of its voluntary insurance business in both the U.S. and Japan. The company has steadily grown its policyholder base and premium income through a combination of organic growth and strategic market penetration. Its ability to adapt its product offerings to market demands has been crucial to this sustained growth.

Future Projections: Analyst projections for Aflac typically forecast modest to steady growth in revenue and earnings. The company is expected to benefit from the ongoing trend of voluntary benefits adoption in the U.S. and its dominant position in the Japanese market. Key drivers for future growth include product innovation, digital transformation, and continued focus on customer acquisition and retention. Projections will vary based on the analyst and the specific time horizon.

Recent Initiatives: Recent initiatives by Aflac have focused on enhancing digital capabilities, improving customer engagement through technology, and expanding its suite of voluntary benefits. The company has also been active in managing its investment portfolio to optimize returns and maintain financial strength. Strategic efforts to streamline operations and enhance efficiency are ongoing.

Summary

Aflac Incorporated is a financially strong company with a leading position in the supplemental insurance markets of the U.S. and Japan. Its core strengths lie in its recognizable brand, established distribution, and consistent dividend history. The company is well-positioned to capitalize on the growing demand for voluntary benefits. However, Aflac must remain vigilant against potential regulatory changes, economic slowdowns, and increasing competition from diversified insurers. Continued investment in digital transformation and product innovation will be crucial for sustained future growth.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Aflac Incorporated Investor Relations
  • Financial news and analysis websites (e.g., Yahoo Finance, Bloomberg)
  • Industry reports on the insurance market

Disclaimers:

This JSON output is for informational purposes only and does not constitute financial advice. Market share data and competitor information are estimates and may vary depending on the source and specific market segment considered. Financial metrics and future projections are subject to change and market volatility.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Aflac Incorporated

Exchange NYSE
Headquaters Columbus, GA, United States
IPO Launch date 1984-07-19
Chairman & CEO Mr. Daniel Paul Amos
Sector Financial Services
Industry Insurance - Life
Full time employees 12694
Full time employees 12694

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is based in Columbus, Georgia.